Chris Beattie
Direttore Tecnico/Scientifico/R&S presso AQUABOUNTY TECHNOLOGIES, INC.
Profilo
Chris Beattie currently works at ViAqua Therapeutics Ltd., as Director from 2021 and AquaBounty Technologies, Inc., as Chief Scientific Officer from 2022.
Posizioni attive di Chris Beattie
| Società | Posizione | Inizio |
|---|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Direttore/Membro del Consiglio | 01/11/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
- Borsa valori
- Insiders
- Chris Beattie
